153 related articles for article (PubMed ID: 24514437)
1. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
Louis D; More K; Oberoi S; Shah PS
Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
Alcock GS; Liley H
Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
[TBL] [Abstract][Full Text] [Related]
4. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
Li ZH; Wang J; Chen C
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
[TBL] [Abstract][Full Text] [Related]
7. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
Lieberman L; Lopriore E; Baker JM; Bercovitz RS; Christensen RD; Crighton G; Delaney M; Goel R; Hendrickson JE; Keir A; Landry D; La Rocca U; Lemyre B; Maier RF; Muniz-Diaz E; Nahirniak S; New HV; Pavenski K; Dos Santos MCP; Ramsey G; Shehata N;
Br J Haematol; 2022 Jul; 198(1):183-195. PubMed ID: 35415922
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
Gottstein R; Cooke RW
Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD001090. PubMed ID: 24043371
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
[TBL] [Abstract][Full Text] [Related]
11. [Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn"].
Huang FJ; He Y; Tang J; Zhang M; Chen J; Mu DZ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1183-1188. PubMed ID: 36398541
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
[TBL] [Abstract][Full Text] [Related]
13. [High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization].
Monpoux F; Dageville C; Maillotte AM; De Smet S; Casagrande F; Boutté P
Arch Pediatr; 2009 Sep; 16(9):1289-94. PubMed ID: 19586760
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2000; (2):CD000361. PubMed ID: 10796199
[TBL] [Abstract][Full Text] [Related]
15. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
Keir AK; Dunn M; Callum J
J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intravenous Ig and alterations in haematological parameters of infants with isoimmune haemolytic disease.
Freyne B; O'Hare FM; Molloy EJ
Arch Dis Child Fetal Neonatal Ed; 2012 Jan; 97(1):F76-7. PubMed ID: 22171016
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial.
Smits-Wintjens VE; Walther FJ; Rath ME; Lindenburg IT; te Pas AB; Kramer CM; Oepkes D; Brand A; Lopriore E
Pediatrics; 2011 Apr; 127(4):680-6. PubMed ID: 21422084
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK
Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
[TBL] [Abstract][Full Text] [Related]
19. Cochrane Review: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.
Okwundu CI; Okoromah CA; Shah PS
Evid Based Child Health; 2013 Jan; 8(1):204-49. PubMed ID: 23878128
[TBL] [Abstract][Full Text] [Related]
20. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
Elalfy MS; Elbarbary NS; Abaza HW
Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
